Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Ritchie

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Scientific Reports|September 25, 2021
Dissection of the bone marrow microenvironment in hairy cell leukaemia identifies prognostic tumour and immune related biomarkersRachel M Koldej, Ashvind Prabahran, Chin Wee Tan, et al.
Bone Marrow Transplantation|January 23, 2020
Severity of mucositis during allogeneic transplantation impacts post-transplant cyclosporin absorptionJoanne L C Tan, Eric Wong, Ashish Bajel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalanDavid S Ritchie, James Morton, Jeff Szer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2017
Prognostic Limitations of Donor T Cell Chimerism after Myeloablative Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesEric Wong, Kate Mason, Jenny Collins, et al.
British Journal of Haematology|November 26, 2013
Prognostic impact of monocyte count at presentation in mantle cell lymphomaAnupkumar George, Henry Miles Prince, Jeff Szer, et al.
Bone Marrow Transplantation|March 28, 2024
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndromeRay Mun Koo, Eric Wong, Joanne E Davis, et al.
Journal of Leukocyte Biology|July 18, 2020
Impact of age-, cancer-, and treatment-driven inflammation on T cell function and immunotherapyKylie M Quinn, Apriliana E R Kartikasari, Rachel E Cooke, et al.
Transplant Immunology|March 4, 2015
HLA class I associations with EBV+ post-transplant lymphoproliferative disorderKimberley Jones, Leesa Wockner, Alycia Thornton, et al.
American Journal of Hematology|January 4, 2012
Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphomaKimberley Jones, Jamie P Nourse, Colm Keane, et al.
Leukemia Research|August 20, 2010
Alloreactive natural killer cells in hematopoietic stem cell transplantationHollie J Pegram, David S Ritchie, Mark J Smyth, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Scientific Reports|September 25, 2021
Dissection of the bone marrow microenvironment in hairy cell leukaemia identifies prognostic tumour and immune related biomarkersRachel M Koldej, Ashvind Prabahran, Chin Wee Tan, et al.
Bone Marrow Transplantation|January 23, 2020
Severity of mucositis during allogeneic transplantation impacts post-transplant cyclosporin absorptionJoanne L C Tan, Eric Wong, Ashish Bajel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalanDavid S Ritchie, James Morton, Jeff Szer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2017
Prognostic Limitations of Donor T Cell Chimerism after Myeloablative Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesEric Wong, Kate Mason, Jenny Collins, et al.
British Journal of Haematology|November 26, 2013
Prognostic impact of monocyte count at presentation in mantle cell lymphomaAnupkumar George, Henry Miles Prince, Jeff Szer, et al.
Bone Marrow Transplantation|March 28, 2024
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndromeRay Mun Koo, Eric Wong, Joanne E Davis, et al.
Journal of Leukocyte Biology|July 18, 2020
Impact of age-, cancer-, and treatment-driven inflammation on T cell function and immunotherapyKylie M Quinn, Apriliana E R Kartikasari, Rachel E Cooke, et al.
Transplant Immunology|March 4, 2015
HLA class I associations with EBV+ post-transplant lymphoproliferative disorderKimberley Jones, Leesa Wockner, Alycia Thornton, et al.
American Journal of Hematology|January 4, 2012
Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphomaKimberley Jones, Jamie P Nourse, Colm Keane, et al.
Leukemia Research|August 20, 2010
Alloreactive natural killer cells in hematopoietic stem cell transplantationHollie J Pegram, David S Ritchie, Mark J Smyth, et al.
Pageof 10